Inventory Summary of Genus plc

Genus plc's latest annual inventory in 2024 was 89.4 Million USD , down -17.24% from previous year.
Genus plc's latest quarterly inventory in 2024 FY was 113.02 Million USD , up 4.64% from previous quarter.
Genus plc reported annual inventory of 108.01 Million USD in 2023, up 5.65% from previous year.
Genus plc reported annual inventory of 102.23 Million USD in 2022, down -3.39% from previous year.
Genus plc reported quarterly inventory of 89.4 Million GBP for 2024 Q3, down -27.3% from previous quarter.
Genus plc reported quarterly inventory of 96.6 Million GBP for 2024 Q1, down -10.57% from previous quarter.

Annual Inventory Chart of Genus plc (2024 - 1996)

Historical Annual Inventory of Genus plc (2024 - 1996)

Year	Inventory	Inventory Growth
2024	89.4 Million USD	-17.24%
2023	108.01 Million USD	5.65%
2022	102.23 Million USD	-3.39%
2021	105.81 Million USD	10.93%
2020	95.38 Million USD	-1.51%
2019	96.85 Million USD	3.03%
2018	94 Million GBP	-32.37%
2017	138.98 Million GBP	1.83%
2016	136.48 Million GBP	65.64%
2015	82.4 Million GBP	10.31%
2014	74.7 Million GBP	-0.93%
2013	75.4 Million GBP	12.54%
2012	67 Million GBP	10.2%
2011	60.8 Million GBP	95.5%
2010	31.1 Million GBP	11.07%
2009	28 Million GBP	28.44%
2008	21.8 Million GBP	15.96%
2007	18.8 Million GBP	3.87%
2006	18.1 Million GBP	4.05%
2005	17.39 Million GBP	7.16%
2004	16.23 Million GBP	-7.98%
2003	17.64 Million GBP	19.79%
2002	14.72 Million GBP	3.77%
2001	14.19 Million GBP	-2.41%
2000	14.54 Million GBP	565.84%
1999	2.18 Million GBP	-11.58%
1998	2.47 Million GBP	-11.97%
1997	2.8 Million GBP	-5.68%
1996	2.97 Million GBP	0.0%

Year	Inventory	Inventory Growth
2024 FY	113.02 Million USD	4.64%
2024 Q3	89.4 Million GBP	-27.3%
2024 Q1	96.6 Million GBP	-10.57%
2024 Q2	122.97 Million GBP	27.3%
2024 Q4	89.4 Million GBP	0.0%
2023 Q3	85.1 Million GBP	-21.9%
2023 Q4	108.01 Million USD	26.93%
2023 Q2	108.96 Million USD	20.94%
2023 FY	108.01 Million USD	5.65%
2023 Q1	90.1 Million GBP	7.26%
2022 Q1	80.9 Million GBP	-23.55%
2022 Q2	80.9 Million GBP	0.0%
2022 Q3	84 Million GBP	3.83%
2022 Q4	84 Million GBP	0.0%
2022 FY	102.23 Million USD	-3.39%
2021 Q3	76.6 Million GBP	-23.45%
2021 Q4	105.81 Million GBP	38.15%
2021 Q1	73.2 Million GBP	-23.26%
2021 Q2	100.06 Million GBP	36.69%
2021 FY	105.81 Million USD	10.93%
2020 FY	95.38 Million USD	-1.51%
2020 Q1	79.8 Million GBP	-17.61%
2020 Q4	95.38 Million GBP	23.56%
2020 Q3	77.2 Million GBP	-26.97%
2020 Q2	105.71 Million GBP	32.48%
2019 Q3	76.1 Million GBP	12.57%
2019 FY	96.85 Million USD	3.03%
2019 Q1	67.6 Million GBP	-5.06%
2019 Q2	67.6 Million GBP	0.0%
2019 Q4	96.85 Million GBP	27.27%
2018 Q1	103 Million GBP	33.94%
2018 Q3	71.2 Million GBP	-30.87%
2018 Q4	71.2 Million GBP	0.0%
2018 FY	94 Million GBP	-32.37%
2018 Q2	103 Million GBP	0.0%
2017 Q4	76.9 Million GBP	0.0%
2017 FY	138.98 Million GBP	1.83%
2017 Q3	76.9 Million GBP	-30.34%
2017 Q2	110.4 Million GBP	0.0%
2017 Q1	110.4 Million GBP	8.13%
2016 Q1	85.3 Million GBP	3.52%
2016 Q3	102.1 Million GBP	19.7%
2016 Q4	102.1 Million GBP	0.0%
2016 FY	136.48 Million GBP	65.64%
2016 Q2	85.3 Million GBP	0.0%
2015 Q2	77.1 Million GBP	0.0%
2015 Q1	77.1 Million GBP	3.21%
2015 FY	82.4 Million GBP	10.31%
2015 Q3	82.4 Million GBP	6.87%
2015 Q4	82.4 Million GBP	0.0%
2014 Q1	74.7 Million GBP	-0.93%
2014 FY	74.7 Million GBP	-0.93%
2014 Q4	74.7 Million GBP	0.0%
2014 Q2	74.7 Million GBP	0.0%
2014 Q3	74.7 Million GBP	0.0%
2013 Q2	69.1 Million GBP	0.0%
2013 Q3	75.4 Million GBP	9.12%
2013 FY	75.4 Million GBP	12.54%
2013 Q4	75.4 Million GBP	0.0%
2012 Q2	33 Million GBP	0.0%
2012 FY	67 Million GBP	10.2%
2012 Q4	67 Million GBP	0.0%
2011 Q4	60.8 Million GBP	0.0%
2011 FY	60.8 Million GBP	95.5%
2011 Q2	31 Million GBP	0.0%
2010 Q4	31.1 Million GBP	0.0%
2010 Q2	28.5 Million GBP	0.0%
2010 FY	31.1 Million GBP	11.07%
2009 Q4	28 Million GBP	0.0%
2009 FY	28 Million GBP	28.44%
2009 Q2	32.5 Million GBP	0.0%
2008 FY	21.8 Million GBP	15.96%
2008 Q4	21.8 Million GBP	0.0%
2008 Q2	19.3 Million GBP	0.0%
2007 Q4	18.8 Million GBP	0.0%
2007 Q2	16.4 Million GBP	0.0%
2007 FY	18.8 Million GBP	3.87%
2006 Q3	21.48 Million GBP	0.0%
2006 FY	18.1 Million GBP	4.05%
2006 Q1	19.12 Million GBP	0.0%
2005 FY	17.39 Million GBP	7.16%
2005 Q1	18 Million GBP	0.0%
2005 Q3	17.39 Million GBP	0.0%
2004 FY	16.23 Million GBP	-7.98%
2004 Q3	16.23 Million GBP	0.0%
2004 Q1	17.47 Million GBP	0.0%
2003 FY	17.64 Million GBP	19.79%
2002 FY	14.72 Million GBP	3.77%
2001 FY	14.19 Million GBP	-2.41%
2000 FY	14.54 Million GBP	565.84%
1999 FY	2.18 Million GBP	-11.58%
1998 FY	2.47 Million GBP	-11.97%
1997 FY	2.8 Million GBP	-5.68%
1996 FY	2.97 Million GBP	0.0%

Peer Inventory Comparison of Genus plc

Name	Inventory	Inventory Difference
Eiger BioPharmaceuticals, Inc.	1.55 Million USD	-5645.501%
Nanobac Pharmaceuticals, Incorporated	10.3 Thousand USD	-867608.434%
SQZ Biotechnologies Company	- USD	-Infinity%
Evofem Biosciences, Inc.	1.69 Million USD	-5168.12%
Santhera Pharmaceuticals Holding AG	2.15 Million USD	-4056.212%
Mesoblast Limited	1.00 USD	-8939999900.0%
Propanc Biopharma, Inc.	- USD	-Infinity%
VioQuest Pharmaceuticals, Inc.	- USD	-Infinity%
CNBX Pharmaceuticals Inc.	-94.61 Thousand USD	94591.185%
Marizyme, Inc.	24.85 Thousand USD	-359586.18%
ContraFect Corporation	- USD	-Infinity%
Nymox Pharmaceutical Corporation	16 Thousand USD	-558650.0%
PsyBio Therapeutics Corp.	- USD	-Infinity%
Sienna Biopharmaceuticals, Inc.	- USD	-Infinity%
RegeneRx Biopharmaceuticals, Inc.	- USD	-Infinity%
Intellipharmaceutics International Inc.	1.00 USD	-8939999900.0%
AXIM Biotechnologies, Inc.	- USD	-Infinity%
MultiCell Technologies, Inc.	- USD	-Infinity%
Accustem Sciences Inc.	- USD	-Infinity%
RVL Pharmaceuticals plc	784 Thousand USD	-11303.061%
EV Biologics, Inc.	- USD	-Infinity%
Q BioMed Inc.	- USD	-Infinity%
Emmaus Life Sciences, Inc.	1.71 Million USD	-5125.015%
Neon Bloom, Inc.	7938.00 USD	-1126128.269%
Mosaic ImmunoEngineering Inc.	- USD	-Infinity%
Biomind Labs Inc.	- USD	-Infinity%
TetraLogic Pharmaceuticals Corporation	- USD	-Infinity%
Pharming Group N.V.	56.76 Million USD	-57.505%
Oncotelic Therapeutics, Inc.	- USD	-Infinity%
Skye Bioscience, Inc.	- USD	-Infinity%
Therapeutic Solutions International, Inc.	22.57 Thousand USD	-395930.832%
THC Farmaceuticals, Inc.	- USD	-Infinity%
Arch Therapeutics, Inc.	1.36 Million USD	-6451.831%
IMV Inc.	2.00 USD	-4469999900.0%
Acro Biomedical Co., Ltd.	12 Thousand USD	-744900.0%
Curative Biotechnology, Inc.	-115.62 Thousand USD	77418.919%
GB Sciences, Inc.	- USD	-Infinity%
Alpha Cognition Inc.	90.41 Thousand USD	-98779.586%
HST Global, Inc.	- USD	-Infinity%
CSL Limited	5.96 Billion USD	98.501%
Halberd Corporation	- USD	-Infinity%
Enzolytics Inc.	- USD	-Infinity%
Resverlogix Corp.	2.37 Million USD	-3670.561%
Affymax, Inc.	- USD	-Infinity%
SYBLEU INC	- USD	-Infinity%
Nuo Therapeutics, Inc.	209.58 Thousand USD	-42554.91%
argenx SE	310.55 Million USD	71.212%
MetaStat, Inc.	- USD	-Infinity%
Northwest Biotherapeutics, Inc.	- USD	-Infinity%
Enzon Pharmaceuticals, Inc.	- USD	-Infinity%
Arno Therapeutics, Inc.	- USD	-Infinity%
RespireRx Pharmaceuticals Inc.	- USD	-Infinity%
GeneThera, Inc.	- USD	-Infinity%
Inhibitor Therapeutics, Inc.	- USD	-Infinity%
AVAX Technologies, Inc.	11.52 Thousand USD	-775941.667%
Zenith Capital Corp.	3.00 USD	-2979999900.0%
Genscript Biotech Corporation	53.33 Million USD	-67.631%
Ember Therapeutics, Inc.	- USD	-Infinity%
Anthera Pharmaceuticals, Inc.	- USD	-Infinity%
Sigyn Therapeutics, Inc.	50 Thousand USD	-178700.0%
WPD Pharmaceuticals Inc.	0.25 USD	-35759999900.0%
American Oriental Bioengineering, Inc.	20.57 Million USD	-334.596%
Provectus Biopharmaceuticals, Inc.	- USD	-Infinity%
Adynxx, Inc.	- USD	-Infinity%
Helix BioMedix, Inc.	- USD	-Infinity%
GlobeStar Therapeutics Corporation	- USD	-Infinity%
VitaSpring Biomedical Co. Ltd.	- USD	-Infinity%
Capstone Therapeutics Corp.	12.83 Million USD	-596.37%
Cotinga Pharmaceuticals Inc.	0.98 USD	-9122448879.592%
BioStem Technologies, Inc.	658.67 Thousand USD	-13472.641%
ONE Bio Corp.	4.5 Million USD	-1884.371%
Reve Technologies, Inc.	- USD	-Infinity%
Burzynski Research Institute, Inc.	- USD	-Infinity%
Wesana Health Holdings Inc.	1.00 USD	-8939999900.0%
Agentix Corp.	- USD	-Infinity%
LadRx Corporation	- USD	-Infinity%
Cell Source, Inc.	- USD	-Infinity%
ProtoKinetix, Incorporated	- USD	-Infinity%
Regen BioPharma, Inc.	- USD	-Infinity%
Regen BioPharma, Inc.	- USD	-Infinity%
NovAccess Global Inc.	- USD	-Infinity%
Endonovo Therapeutics, Inc.	- USD	-Infinity%
Itoco Inc.	- USD	-Infinity%
Rasna Therapeutics, Inc.	-20.67 Thousand USD	432589.962%
Pathfinder Cell Therapy, Inc.	- USD	-Infinity%
Kadimastem Ltd	- USD	-Infinity%
Oncology Pharma Inc.	- USD	-Infinity%
Institute of Biomedical Research Corp.	- USD	-Infinity%
CytoDyn Inc.	- USD	-Infinity%
Claritas Pharmaceuticals, Inc.	- USD	-Infinity%
NDT Pharmaceuticals Inc.	- USD	-Infinity%
Mobile Lads Corp.	- USD	-Infinity%
NanoSphere Health Sciences Inc.	-8.71 USD	1026406529.392%
Qrons Inc.	- USD	-Infinity%
Alseres Pharmaceuticals, Inc.	- USD	-Infinity%
Advanced Proteome Therapeutics Corporation	- USD	-Infinity%
Nascent Biotech, Inc.	- USD	-Infinity%
Rebus Holdings, Inc.	- USD	-Infinity%
ImmunoCellular Therapeutics, Ltd.	- USD	-Infinity%
International Stem Cell Corporation	1.26 Million USD	-6978.385%
Bioxytran, Inc.	- USD	-Infinity%
GlobeImmune, Inc.	- USD	-Infinity%
Predictive Technology Group, Inc.	- USD	-Infinity%
ProText Mobility, Inc.	15 Million USD	-496.0%
Cardax, Inc.	- USD	-Infinity%
VG Life Sciences Inc.	- USD	-Infinity%
Kaleido Biosciences, Inc.	- USD	-Infinity%
Advaxis, Inc.	- USD	-Infinity%
Adhera Therapeutics, Inc.	- USD	-Infinity%
RenovaCare, Inc.	- USD	-Infinity%
Regnum Corp.	- USD	-Infinity%
Innovation Pharmaceuticals Inc.	- USD	-Infinity%
Neutra Corp.	- USD	-Infinity%
Windtree Therapeutics, Inc.	- USD	-Infinity%
PureTech Health plc	- USD	-Infinity%
Coeptis Therapeutics, Inc.	- USD	-Infinity%
IXICO plc	1.00 USD	-8939999900.0%
IntelGenx Technologies Corp.	71 Thousand USD	-125815.493%
Gelesis Holdings, Inc.	6.86 Million USD	-1202.258%
CSL Limited	5.96 Billion USD	98.501%
Cellectis S.A.	1.00 USD	-8939999900.0%

Global Stocks Search

Genus plc (GENSF)

Inventory Summary of Genus plc

Annual Inventory Chart of Genus plc (2024 - 1996)

Historical Annual Inventory of Genus plc (2024 - 1996)

Peer Inventory Comparison of Genus plc